In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

The researchers theorise the protective effects of these drugs could be because they reduce inflammation, control infections ...

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

Opening for a new type of drug for Alzheimer's disease. ScienceDaily . Retrieved February 12, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250211134459.htm ...

The drug was renamed simufilam in August of 2020, and in preliminary studies, patients started showing improvement after just a month — “extraordinary for any Alzheimer’s trial,” writes ...

A revolutionary new drug called RI-AG03 has demonstrated remarkable potential in preventing the devastating effects of Alzheimer‘s disease. The medication specifically targets tau proteins ...

Antimicrobials, vaccines, anti-inflammatories linked to reduced risk for Alzheimer disease and dementia; antipsychotics and diabetes drugs tied to higher risk.

Alzheimer's disease, a major health issue, may benefit from common drugs and early interventions. In a new thesis from the Department of Medical Epidemiology and Biostatistics, Ph.D. student Bowen ...

A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. This is the finding of research from the University of Gothenburg, which also ...

Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...